
 a16z Podcast The Science and Supply of GLP-1s
 58 snips 
 Jun 19, 2024  Brooke Boyarsky-Pratt, the CEO of KnownWell, revolutionizes the obesity medicine landscape with her personal journey battling obesity. She discusses the critical role of obesity-specific practitioners and patient-centric medical homes in fostering trust. The conversation delves into the science and impact of GLP-1 medications, highlighting their tailored applications in treatment. The challenges of cost and supply in the obesity sector are addressed, alongside a vision for a more empathetic, comprehensive approach to obesity care. 
 AI Snips 
 Chapters 
 Transcript 
 Episode notes 
Brooke's Inspiration
- Brooke Boyarsky-Pratt's pediatrician suggested "fat camp", negatively impacting her healthcare interactions.
 - This experience fueled her passion to create patient-centered care for individuals with obesity.
 
Obesity Medicine Defined
- Obesity medicine is a medical specialty focusing on comprehensive treatment of overweight and obesity.
 - It addresses weight loss and related conditions like diabetes and hyperlipidemia.
 
PCP Challenges
- Primary care doctors often lack sufficient training and resources for effective obesity management.
 - They may struggle with medication understanding, approvals, and providing wraparound services.
 

